Abbott Laboratories
ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irā¦ read more
Healthcare
Medical Devices
46 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$105.70
Price+0.09%
$0.09
1Y
Price
Market Cap
$184.109b
Large
Price/Earnings 3y Avg5y Avg
20.3x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+14.2%
EBITDA Margin+7.4%
Net Profit Margin+7.3%
Free Cash Flow Margin+14.2%
EBITDA Margin+7.4%
Net Profit Margin+7.3%
Free Cash Flow MarginRevenue
$46.585b
+5.1%
1y CAGR+5.1%
3y CAGR+1.8%
5y CAGREarnings
$5.425b
-16.8%
1y CAGR+22.0%
3y CAGR+12.1%
5y CAGREPS
$3.11
-16.4%
1y CAGR+22.0%
3y CAGR+12.4%
5y CAGRBook Value
$51.762b
$109.215b
Assets$57.453b
Liabilities$32.608b
DebtDebt to Assets
29.9%
3.4x
Debt to EBITDAFree Cash Flow
$8.720b
-0.2%
1y CAGR+13.9%
3y CAGR+1.6%
5y CAGRNo items found.
Press Releases
Statements and updates from the company